Spiegelmer Inhibition of MCP‐1/CCR2 – Potential as an Adjunct Immunosuppressive Therapy in Transplantation

E-ISSN： 1365-3083|82|2|102-109

ISSN： 0300-9475

Source： SCANDINAVIAN JOURNAL OF IMMUNOLOGY (ELECTRONIC), Vol.82, Iss.2, 2015-08, pp. : 102-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant Model

Journal of Vascular Research, Vol. 45, Iss. 6, 2008-05 ,pp. : 538-546

Karger

Access to resources Recommend Favorite

Localisation of mRNA for JE/MCP-1 and Its Receptor CCR2 in Atherosclerotic Lesions of the ApoE Knockout Mouse

Journal of Vascular Research, Vol. 37, Iss. 2, 2000-03 ,pp. : 93-102

Karger

Access to resources Recommend Favorite

CD68 and MCP-1/CCR2 Expression of Initial Biopsies Reflect the Outcomes of Membranous Nephropathy

Nephron Clin Pract, Vol. 98, Iss. 1, 2004-11 ,pp. : c25-c34

Karger

Access to resources Recommend Favorite

Cyclophosphamide‐induced tolerance in kidney transplantation avoids long‐term immunosuppressive therapy

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : 112-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tacrolimus (FK506) suppresses TNF-α-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1152-1158

Spandidos Publications

Access to resources Recommend Favorite